190 related articles for article (PubMed ID: 8454349)
1. Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection.
Amsbaugh DF; Li ZM; Shahin RD
Infect Immun; 1993 Apr; 61(4):1447-52. PubMed ID: 8454349
[TBL] [Abstract][Full Text] [Related]
2. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
Kimura A; Mountzouros KT; Relman DA; Falkow S; Cowell JL
Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M; Nagai M
Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
[TBL] [Abstract][Full Text] [Related]
4. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
Cahill ES; O'Hagan DT; Illum L; Redhead K
FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
[TBL] [Abstract][Full Text] [Related]
5. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
Cahill ES; O'Hagan DT; Illum L; Barnard A; Mills KH; Redhead K
Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
[TBL] [Abstract][Full Text] [Related]
6. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
Roberts M; Cropley I; Chatfield S; Dougan G
Vaccine; 1993; 11(8):866-72. PubMed ID: 8356847
[TBL] [Abstract][Full Text] [Related]
8. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
Thomas MG; Ashworth LA; Miller E; Lambert HP
J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
[TBL] [Abstract][Full Text] [Related]
9. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.
Alonso S; Reveneau N; Pethe K; Locht C
Infect Immun; 2002 Aug; 70(8):4142-7. PubMed ID: 12117922
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
11. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
Isacson J; Trollfors B; Hedvall G; Taranger J; Zackrisson G
Scand J Infect Dis; 1995; 27(3):273-7. PubMed ID: 8539553
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.
Shahin RD; Amsbaugh DF; Leef MF
Infect Immun; 1992 Apr; 60(4):1482-8. PubMed ID: 1548072
[TBL] [Abstract][Full Text] [Related]
13. Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories.
Wong KH; Skelton SK
J Clin Microbiol; 1989 Dec; 27(12):2805-10. PubMed ID: 2556434
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.
Hodder SL; Cherry JD; Mortimer EA; Ford AB; Gornbein J; Papp K
Clin Infect Dis; 2000 Jul; 31(1):7-14. PubMed ID: 10913389
[TBL] [Abstract][Full Text] [Related]
15. Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies.
Wilson DR; Siebers A; Finlay BB
Infect Immun; 1998 Oct; 66(10):4884-94. PubMed ID: 9746593
[TBL] [Abstract][Full Text] [Related]
16. Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.
Mielcarek N; Nordström I; Menozzi FD; Locht C; Holmgren J
Infect Immun; 2000 Feb; 68(2):485-91. PubMed ID: 10639408
[TBL] [Abstract][Full Text] [Related]
17. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
18. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
Sato H; Sato Y
Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Bordetella pertussis filamentous hemagglutinin with human TLR2: identification of the TLR2-binding domain.
Asgarian-Omran H; Amirzargar AA; Zeerleder S; Mahdavi M; van Mierlo G; Solati S; Jeddi-Tehrani M; Rabbani H; Aarden L; Shokri F
APMIS; 2015 Feb; 123(2):156-62. PubMed ID: 25353353
[TBL] [Abstract][Full Text] [Related]
20. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.
Renauld-Mongénie G; Mielcarek N; Cornette J; Schacht AM; Capron A; Riveau G; Locht C
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7944-9. PubMed ID: 8755582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
